If this works out, it could conceivably improve symptoms for anyone with an auto-immune disorder
An experimental therapy has shown promise in treating multiple sclerosis without weakening the immune system and could help target other autoimmune and allergic diseases, researchers said on Wednesday.
Multiple sclerosis causes the immune system to misfire and attack myelin, the insulating layer that forms around nerves in the spinal cord, brain and optic nerve.
Current treatments for the disease inhibit the immune system in an effort to prevent the resulting symptoms, like paralysis and blindness.
That places patients at risk of infection and other serious illnesses like cancer.
The phase 1 clinical trial of nine patients in Germany used their white blood cells to stealthily deliver billions of myelin antigens into their bodies.